Research about PEP

Rates of repeat PEP treatments

• Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. (pdf 83KB)
• Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP Study (pdf 273KB)

Effectiveness of PEP

• Non-occupational post-exposure prophylaxis for HIV. (pdf 36KB)
• Prophylaxis Following Nonoccupational Exposure to HIV (pdf 510KB)
• Seroconversion Following Nonoccupational Postexposure Prophylaxis Against HIV (pdf 32KB)
• Guidelines for the management and post exposure prophylaxis of individuals who sustain nonoccupational exposure to HIV. (pdf 161KB)
• HIV Postexposure Prophylaxis in the 21st Century (pdf 94KB)
• Epidemiologically targeted post-exposure prophylaxis against HIV: an under-utilized prevention technology (pdf 44KB)
• Non-occupational Human Immunodeficiency Virus Post-exposure Prophylaxis (pdf 275KB)
• Most people given non-occupational PEP fully adhere to their treatment (pdf 1KB)

Complience to PEP tretments

• Most people given non-occupational PEP fully adhere to their treatment (pdf 1KB)
• Adherence to an Occupational Blood Borne Pathogens Exposure Management Program Among Healthcare Workers and Other Groups at Risk in Argentina (pdf 32KB)